Avanos Medical Inc (AVNS)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 306,500 | 293,600 | 370,000 | 380,300 | 341,500 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $306,500K ÷ $—K
= —
The payables turnover ratio for Avanos Medical Inc has been noted as "—", or not available, for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. The absence of this data may suggest that specific financial information related to payables management and turnover efficiency is not disclosed or readily available for analysis during these periods. Without the payables turnover ratio, it is challenging to assess the company's ability to efficiently manage its accounts payable and utilize suppliers' credit effectively. Investors and stakeholders may benefit from additional disclosures or insights to evaluate Avanos Medical Inc's payables turnover performance in the future.
Peer comparison
Dec 31, 2024